Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × telisotuzumab vedotin × 90 days × Clear all

Status

Recruiting 2 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 1 ulixertinib 1 telisotuzumab vedotin 1 selinexor 1 mifamurtide 1 dodecyl maltoside 1 Sunitinib 1 Peripheral Blood Stem Cell Transplantation 1 Eflornithine 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04830202 2026-02-06

Expanded Access to Telisotuzumab Vedotin

AbbVie

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡